Cargando…

Clinical value of lncRNA MALAT1 as a prognostic marker in human cancer: systematic review and meta-analysis

BACKGROUND: Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) is found to be overexpressed and associated with clinicopathological features in patients with cancer. OBJECTIVES: To evaluate the clinical value of MALAT1 as a prognostic marker in human cancers by a comprehensive meta-anal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, Xiaoling, Xu, Guoxiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2015
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593150/ https://www.ncbi.nlm.nih.gov/pubmed/26423854 http://dx.doi.org/10.1136/bmjopen-2015-008653

Ejemplares similares

Expression and clinical value of lncRNA MALAT1 and lncRNA ANRIL in glaucoma patients
por: Zheng, Miao, et al.
Publicado: (2020)

Epigenetic regulation of cutaneous T-cell lymphoma is mediated by dysregulated lncRNA MALAT1 through modulation of tumor microenvironment
por: Guo, Wei, et al.
Publicado: (2022)

Regulatory Networks of LncRNA MALAT-1 in Cancer
por: Fu, Shijian, et al.
Publicado: (2020)

LncRNA MALAT1 regulates METTL3-mediated PD-L1 expression and immune infiltrates in pancreatic cancer
por: Song, Zhengwei, et al.
Publicado: (2022)

Prognostic significance of lncRNA AP004608.1 in prostate cancer
por: Li, Wei, et al.
Publicado: (2022)

A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for acute myeloid leukemia
por: Li, Pian, et al.
Publicado: (2022)

A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for low grade glioma
por: Wen, Jun, et al.
Publicado: (2023)

LncRNA MALAT1 negatively regulates MDSCs in patients with lung cancer
por: Zhou, Qinfeng, et al.
Publicado: (2018)

Prognostic and Predictive Value of a Long Non-coding RNA Signature in Glioma: A lncRNA Expression Analysis
por: Pan, Yuan-Bo, et al.
Publicado: (2020)

LncRNA HOTAIR: A Potential Prognostic Factor and Therapeutic Target in Human Cancers
por: Xin, Xiaoru, et al.
Publicado: (2021)

LncRNA MALAT1 Promotes Tumor Angiogenesis by Regulating MicroRNA-150-5p/VEGFA Signaling in Osteosarcoma: In-Vitro and In-Vivo Analyses
por: Vimalraj, Selvaraj, et al.
Publicado: (2021)

Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma
por: Li, Wang, et al.
Publicado: (2020)

The role of LncRNA MALAT-1 and MiRNA-9 in Psoriasis
por: Elamir, Azza M., et al.
Publicado: (2021)

The emerging potentials of lncRNA DRAIC in human cancers
por: Yao, Qinfan, et al.
Publicado: (2022)

Role of lncRNA MALAT1 in UVA-induced corneal endothelial senescence
por: Qiao, Yujie, et al.
Publicado: (2023)

Pyroptosis-Related lncRNA Prognostic Model for Renal Cancer Contributes to Immunodiagnosis and Immunotherapy
por: Zhou, Xuan, et al.
Publicado: (2022)

Identification of LncRNA Prognostic Signature Associated With Genomic Instability in Pancreatic Adenocarcinoma
por: Zhu, Jinfeng, et al.
Publicado: (2022)

Prognostic significance and identification of basement membrane-associated lncRNA in bladder cancer
por: Feng, Lixiang, et al.
Publicado: (2022)

LncRNA expression profile during autophagy and Malat1 function in macrophages
por: Ma, Zhanbing, et al.
Publicado: (2019)

Functions and mechanisms of lncRNA MALAT1 in cancer chemotherapy resistance
por: Hou, Junhui, et al.
Publicado: (2023)

LncRNA MALAT1 knockdown inhibits the development of choroidal neovascularization
por: Zhang, Xiaoli, et al.
Publicado: (2023)

LncRNA-MALAT1: A Key Participant in the Occurrence and Development of Cancer
por: Hao, Longhui, et al.
Publicado: (2023)

The lncRNA epigenetics: The significance of m6A and m5C lncRNA modifications in cancer
por: Cusenza, Vincenza Ylenia, et al.
Publicado: (2023)

Meta-analysis of the prognostic value of lncRNA ZFAS1 in patients with solid tumors
por: Song, Wei, et al.
Publicado: (2017)

Immune-Related lncRNA Pairs as Prognostic Signature and Immune-Landscape Predictor in Lung Adenocarcinoma
por: Yin, Zhengrong, et al.
Publicado: (2022)

Identification and Validation of a Novel Six-lncRNA-Based Prognostic Model for Lung Adenocarcinoma
por: Yang, Lingge, et al.
Publicado: (2022)

Characterization of the Prognostic m6A-Related lncRNA Signature in Gastric Cancer
por: Wang, Haixu, et al.
Publicado: (2021)

A novel cuproptosis-related prognostic lncRNA signature and lncRNA MIR31HG/miR-193a-3p/TNFRSF21 regulatory axis in lung adenocarcinoma
por: Mo, Xiaocong, et al.
Publicado: (2022)

The prognostic value and mechanisms of lncRNA UCA1 in human cancer
por: Yao, Fei, et al.
Publicado: (2019)

Meta-analysis of the prognostic value of lncRNA DANCR for cancer patients in China
por: Fan, Yanghua, et al.
Publicado: (2019)

Prognostic Value of LncRNA HOTAIR in Colorectal Cancer: A Meta-analysis
por: Chen, Shuangqian, et al.
Publicado: (2020)

The Prognostic Value of LncRNA SLNCR1 in Cancers: A Meta-Analysis
por: Cong, Lele, et al.
Publicado: (2021)

Integrated Analysis of a Competing Endogenous RNA Network Reveals a Prognostic lncRNA Signature in Bladder Cancer
por: Peng, Mou, et al.
Publicado: (2021)

The prognostic value of lncRNA SNHG6 in cancer patients
por: Shen, Haixiang, et al.
Publicado: (2020)

Prognostic value of glycolysis markers in pancreatic cancer: A systematic review and meta-analysis
por: Wang, Chengcheng, et al.
Publicado: (2022)

Editorial: The Role of lncRNA in Cancer Metabolism
por: Huang, Guo-Liang, et al.
Publicado: (2021)

The Role of lncRNA PCAT6 in Cancers
por: Wang, Siying, et al.
Publicado: (2021)

The lncRNA MALAT1 is a novel biomarker for gastric cancer metastasis
por: Xia, Hongwei, et al.
Publicado: (2016)

EPC‐derived exosomes promote osteoclastogenesis through LncRNA‐MALAT1
por: Cui, Yigong, et al.
Publicado: (2019)

The Role of the lncRNA MALAT1 in Neuroprotection against Hypoxic/Ischemic Injury
por: Wang, Liping, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ded68qsp2f6ma48h44imr4jnh6